Skip to content
10-Q

Quarterly Report

BIOVIE INC. BIVI BIVIW

0001520138-25-000144

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · May 5, 2025 18.56M sh
Cash And Equivalents Q3 2025 · Mar 31, 2025 $23.15M
Cash And Equivalents Q3 2025 · Jun 30, 2024 $23.84M
Current Liabilities Q3 2025 · Mar 31, 2025 $2.55M
Current Liabilities Q3 2025 · Jun 30, 2024 $9.35M
Total Liabilities Q3 2025 · Mar 31, 2025 $2.84M
Total Liabilities Q3 2025 · Jun 30, 2024 $9.7M
Current Assets Q3 2025 · Mar 31, 2025 $23.72M
Current Assets Q3 2025 · Jun 30, 2024 $24.05M
Total Assets Q3 2025 · Mar 31, 2025 $24.66M
Total Assets Q3 2025 · Jun 30, 2024 $25.21M
Sga Expense Q3 2025 · Mar 31, 2025 $1.59M
Sga Expense Q3 2025 · Mar 31, 2025 $6.19M
Sga Expense Q3 2025 · Mar 31, 2024 $1.97M
Sga Expense Q3 2025 · Mar 31, 2024 $6.17M
Shares Diluted restated Q3 2025 · Mar 31, 2024 4.48M sh
Shares Diluted restated Q3 2025 · Mar 31, 2024 3.99M sh
Operating Cash Flow Q3 2025 · Mar 31, 2024 −$23.94M
Stockholders Equity Q3 2025 · Mar 31, 2024 $18.93M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.49M
Stockholders Equity Q3 2025 · Sep 30, 2023 $7.55M
Stockholders Equity Q3 2025 · Jun 30, 2023 $15.34M
Eps Diluted restated Q3 2025 · Mar 31, 2024 −$2.00
Eps Diluted restated Q3 2025 · Mar 31, 2024 −$7.04
Eps Basic restated Q3 2025 · Mar 31, 2024 −$2.00
Eps Basic restated Q3 2025 · Mar 31, 2024 −$7.04
Rd Expense Q3 2025 · Mar 31, 2024 $5.7M
Rd Expense Q3 2025 · Mar 31, 2024 $21.05M
Net Income Q3 2025 · Mar 31, 2024 −$8.07M
Net Income Q3 2025 · Dec 31, 2023 −$8.4M
Net Income Q3 2025 · Sep 30, 2023 −$10.71M
Operating Income Q3 2025 · Mar 31, 2024 −$7.73M
Operating Income Q3 2025 · Mar 31, 2024 −$27.39M